Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Seven Eight Capital LP increased its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 45,906 shares of the biopharmaceutical company’s stock after purchasing an additional 26,831 shares during the […]
Seven Eight Capital LP increased its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 140.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,906 shares of the biopharmaceutical company’s stock after acquiring an additional 26,831 shares during the quarter. Seven […]
NOVATO, Calif., June 04, 2024 (GLOBE NEWSWIRE) Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare
Ultragenyx Pharmaceutical (NASDAQ:RARE) PT Raised to $115 00 wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.